|
UBA2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.14970272086157E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.35811370430383E-13 |
| Normal-vs-Stage2 |
2.643800E-03 |
| Normal-vs-Stage3 |
3.803300E-04 |
| Normal-vs-Stage4 |
6.160200E-04 |
| Stage1-vs-Stage2 |
1.713840E-01 |
| Stage1-vs-Stage3 |
5.421500E-03 |
| Stage1-vs-Stage4 |
5.218200E-02 |
| Stage2-vs-Stage3 |
5.462400E-01 |
| Stage2-vs-Stage4 |
8.200000E-01 |
| Stage3-vs-Stage4 |
6.850800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.0093709442508E-12 |
| Normal-vs-AfricanAmerican |
1.236350E-01 |
| Normal-vs-Asian |
6.896100E-02 |
| Caucasian-vs-AfricanAmerican |
7.599500E-03 |
| Caucasian-vs-Asian |
5.194800E-01 |
| AfricanAmerican-vs-Asian |
8.954000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.16950013509631E-10 |
| Normal-vs-Female |
2.07439999622139E-08 |
| Male-vs-Female |
8.339600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.349600E-02 |
| Normal-vs-Age(41-60Yrs) |
9.82509962277334E-10 |
| Normal-vs-Age(61-80Yrs) |
8.37039992873656E-10 |
| Normal-vs-Age(81-100Yrs) |
2.444000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.659000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.166800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.731600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.205000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.331420E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.273420E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.784900E-03 |
| Normal-vs-Grade 2 |
1.64912528077821E-12 |
| Normal-vs-Grade 3 |
1.63518999999335E-05 |
| Normal-vs-Grade 4 |
4.131800E-02 |
| Grade 1-vs-Grade 2 |
4.536600E-01 |
| Grade 1-vs-Grade 3 |
1.927840E-02 |
| Grade 1-vs-Grade 4 |
4.152300E-02 |
| Grade 2-vs-Grade 3 |
8.31740000000192E-05 |
| Grade 2-vs-Grade 4 |
1.080310E-03 |
| Grade 3-vs-Grade 4 |
4.886200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62447832963153E-12 |
| Normal-vs-ccB subtype |
1.575860E-04 |
| ccA subtype-vs-ccB subtype |
1.00830000004937E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.31990000543192E-08 |
| Normal-vs-N1 |
1.526770E-01 |
| N0-vs-N1 |
8.999200E-01 |
|
|
